Pages that link to "Q41301275"
Jump to navigation
Jump to search
The following pages link to Pharmacology of AMPA antagonists and their role in neuroprotection (Q41301275):
Displaying 23 items.
- Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death (Q28217736) (← links)
- Synaptic control of motoneuronal excitability. (Q30360691) (← links)
- In vivo, the direct and seizure-induced neuronal cytotoxicity of kainate and AMPA is modified by the non-competitive antagonist, GYKI 52466. (Q31872214) (← links)
- Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders (Q33863397) (← links)
- Ca2+-Zn2+ permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration (Q33976267) (← links)
- Excitotoxicity in glial cells. (Q34768751) (← links)
- Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity (Q35196234) (← links)
- Glutamate-mediated glial injury: mechanisms and clinical importance (Q36277315) (← links)
- Mild acidosis enhances AMPA receptor-mediated intracellular zinc mobilization in cortical neurons. (Q41847852) (← links)
- Decreased dendrite growth from cultured mouse cortical neurons surviving excitotoxic activation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate/kainate receptors (Q42167678) (← links)
- Direct interaction between GluR2 and GAPDH regulates AMPAR-mediated excitotoxicity (Q42254337) (← links)
- The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activity. (Q43698586) (← links)
- Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia (Q43823127) (← links)
- Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia (Q43915735) (← links)
- Inherent desensitisation-preventing properties of a novel, subtype-selective AMPA receptor agonist, (S)-CPW 399, as a possible explanation for its excitotoxic action in cultured cerebellar granule cells (Q44291008) (← links)
- Characterization of the mechanism of anticonvulsant activity for a selected set of putative AMPA receptor antagonists (Q44301650) (← links)
- Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures (Q44413927) (← links)
- Effects of metabotropic glutamate receptor stimulation on blood-brain barrier permeability during focal cerebral ischemia (Q45143468) (← links)
- AMPA-preferring glutamate receptors in cochlear physiology of adult guinea-pig. (Q46941093) (← links)
- Stereoselective neuroprotection by novel 2,3-benzodiazepine non-competitive AMPA antagonist against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures (Q48226127) (← links)
- Recent developments on triazole nucleus in anticonvulsant compounds: a review (Q49564600) (← links)
- Design, synthesis, and pharmacological characterization of polyamine toxin derivatives: potent ligands for the pore-forming region of AMPA receptors. (Q51980443) (← links)
- LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia (Q73898225) (← links)